EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

empaveli pegcetacoplan 1080 mg/20 ml injection solution vial

swedish orphan biovitrum pty ltd - pegcetacoplan, quantity: 1080 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium acetate trihydrate; glacial acetic acid; sorbitol - empaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who have an inadequate response to, or are intolerant of, a c5 inhibitor.

DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

doptelet avatrombopag (as maleate) 20 mg film-coated tablets blister pack

swedish orphan biovitrum pty ltd - avatrombopag maleate, quantity: 23.6 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; crospovidone; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.,doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (itp) who have had an insufficient response to a previous treatment.

Bioenergy Greens Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bioenergy greens

high valley contract manufacturing (gmp) sdn bhd - wheat (triticum aestivum) sprout powder; laminaria japonica aresch; hordeum vulgare (barley); cichorium intybus (chicory) root extract; chlorella (chlorella regularis); brown rice (oryza sativa l.) powder -

Elocta European Union - English - EMA (European Medicines Agency)

elocta

swedish orphan biovitrum ab (publ) - efmoroctocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).

Elocta 1,000unit powder and solvent for solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elocta 1,000unit powder and solvent for solution for injection vials

swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 1000unit

Elocta 1,500unit powder and solvent for solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elocta 1,500unit powder and solvent for solution for injection vials

swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 1500unit

Elocta 2,000unit powder and solvent for solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elocta 2,000unit powder and solvent for solution for injection vials

swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 2000unit

Elocta 250unit powder and solvent for solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

elocta 250unit powder and solvent for solution for injection vials

swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 250unit